Update on the treatment of type 2 diabetes mellitus

To achieve good metabolic control in diabetes and keep long term, a combination of changes in lifestyle and pharmacological treatment is necessary. Achieving nearnormal glycated hemoglobin significantly, decreases risk of macrovascular and microvascular complications. At present there are different...

Full description

Saved in:
Bibliographic Details
Published in:World journal of diabetes 2016-09, Vol.7 (17), p.354-395
Main Authors: Juan Jose Marin-Penalver, Iciar Martin-Timon, Cristina Sevillano-Collantes, Francisco Javier del Canizo-Gomez
Format: Article
Language:English
Subjects:
agents
antidiabetic
diabetes
Future
impairment
Injectable
mellitus
Older
Oral
people
Renal
Review
Treatment
treatments
Type
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To achieve good metabolic control in diabetes and keep long term, a combination of changes in lifestyle and pharmacological treatment is necessary. Achieving nearnormal glycated hemoglobin significantly, decreases risk of macrovascular and microvascular complications. At present there are different treatments, both oral and injectable, available for the treatment of type 2 diabetes mellitus (T2DM). Treatment algorithms designed to reduce the development or progression of the complications of diabetes emphasizes the need for good glycaemic control. The aim of this review is to perform an update on the benefits and limitations of different drugs, both current and future, for the treatment of T2DM. Initial intervention should focus on lifesty lechanges. Moreover, changes in lifestyle have proven to be beneficial, but for many patients is a complication keep long term. Physicians should be familiar with the different types of existing drugs for the treatment of diabetes and select the most effective, safe and better tolerated by patients. Metformin remains the first choice of treatment for most patients. Other alternative or second-line treatment options should be individualized depending on thecharacteristics of each patient. This article reviews the treatments available for patients with T2DM, with an emphasis on agents introduced within the last decade.
ISSN:1948-9358
1948-9358
DOI:10.4239/wjd.v7.i17.354